Skip to main content
. 2023 Mar 14;16:769–777. doi: 10.2147/DMSO.S392161

Figure 5.

Figure 5

HbAc1 levels before and after treatment with MSCs. There was a significant decrease in the HbAc1 levels in all trials. After follow up, the HbAc1 levels reduced to 1.2%, 32%,26%,7.1%, 31% and 6% for T1, T2, T3, T4, T5, and T6 respectively.